Sonara Health
Dallas, US · Founded 2020 · Delaware corporation · 18 employees on LinkedIn · 7 known investors
Sonara provides a hybrid care model for opioid treatment programs that combines at-home medication management with remote monitoring and clinical oversight. The platform enables patients to take methadone at home while maintaining secure connection to care teams, designed to expand treatment access while reducing barriers to adherence.
Founders & leadership
MG
Michael GilesChief Executive Officer
JG
JUSTIN GELLERExecutive
Board
RK
RACHEL KERNBoard director
DR
DANIEL R. KARLINBoard director
Investors · 7
Boomerang VenturesIndianapolis · $250K – $1.5M
Royal Street Ventures Management Company, LlcKansas City · $1M – $3M
Acumen Americareported$250K – $500K
First Trust Capital PartnersreportedWheaton · $5M
Sorenson Impact FoundationreportedSalt Lake City
Also in the syndicate · 2
Oakwood Circle VenturesRoyal Street Ventures
Reported raises · per SEC filings
Form D private placements$8.8M disclosed across 4 of 5 rounds · 2021–2025
▶$4.7MraisedMay 2025 · 11 investors · Other Health CareRule 506(b)
▶$4.7MraisedMay 2025 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL R. KARLINDirector
- MICHAEL GILESExecutive Officer, Director
- JUSTIN GELLERExecutive Officer
- RACHEL KERNDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.3MraisedOct 2022 · 5 investors · Other Health CareRule 506(b)
▶$2.3MraisedOct 2022 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DANIEL R. KARLINDirector
- RACHEL KERNDirector
- MICHAEL GILESExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $2.3M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.3MraisedSep 2022 · 19 investors · Other Health CareRule 506(b)
▶$1.3MraisedSep 2022 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL GILESExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $1.3M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$550KraisedSep 2022 · 17 investors · Other Health CareRule 506(b)
▶$550KraisedSep 2022 · 17 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- MICHAEL GILESExecutive Officer, Director
- Offering amount
- $550K
- Amount sold
- $550K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Sonara Health do?
- Sonara provides a hybrid care model for opioid treatment programs that combines at-home medication management with remote monitoring and clinical oversight. The platform enables patients to take methadone at home while maintaining secure connection to care teams, designed to expand treatment access while reducing barriers to adherence.
- Who are Sonara Health's investors?
- Sonara Health's investors include Boomerang Ventures, Royal Street Ventures Management Company, Llc, Acumen America, First Trust Capital Partners, Sorenson Impact Foundation.
- How much funding has Sonara Health raised?
- Sonara Health has disclosed $8.8M raised across 4 of its 5 known rounds.
- Where is Sonara Health headquartered?
- Sonara Health is headquartered in Dallas, US.